Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HME Insider Trading

HME | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HME provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2012-03-16 21:05 2012-03-15 HELBIG LEONARD F III Director SELL $59.77 5,500 $328,739 43,861 -11.1%
2012-03-15 22:42 2012-03-13 DOYLE SCOTT Officer - Senior Vice President OPT+S $60.01 7,167 $430,100 43,651 0.0%
2012-03-13 21:49 2012-03-09 Quinn Bernard J. Officer - Senior Vice President OPT+S $59.31 4,000 $237,236 18,739 0.0%
2012-03-13 21:48 2012-03-09 BLANK STEPHEN R Director OPT+S $59.35 3,370 $199,999 4,269 0.0%
2011-11-09 21:05 2011-11-08 Lydon Thomas P Jr Director BUY $58.60 1,750 $102,550 3,550 +97.2%
2011-09-09 21:37 2011-09-08 SMITH JOHN E Officer - Senior Vice President OPT+S $66.15 31,538 $2,086,384 52,298 0.0%
2011-09-01 18:51 2011-08-31 Hague Donald R. Officer - Senior Vice President OPT+S $66.50 1,991 $132,402 12,261 0.0%
2011-08-18 18:54 2011-08-17 HELBIG LEONARD F III Director OPT+S $64.66 6,400 $413,823 48,038 0.0%
2011-08-18 18:39 2011-08-17 DOYLE SCOTT Officer - Senior Vice President OPT+S $64.54 6,855 $442,428 42,029 0.0%
2011-08-17 19:24 2011-08-15 Hague Donald R. Officer - Senior Vice President OPT+S $63.01 1,959 $123,430 11,955 0.0%
2011-08-17 18:40 2011-08-16 TAIT AMY L Director SELL $64.00 1,600 $102,400 1,436 -52.7%
2011-08-15 22:00 2011-08-11 TAIT AMY L Director OPT+S $62.25 7,400 $460,659 25,735 0.0%
2011-07-01 17:24 2011-06-30 PETTINELLA EDWARD J Director, Officer - CEO OPT+S $60.76 50,000 $3,037,995 257,614 0.0%
2011-06-01 19:05 2011-05-31 LUKEN ROBERT Officer - Senior Vice President SELL $61.17 1,685 $103,069 35,603 -4.5%
2011-05-17 22:53 2011-05-16 Hague Donald R. Officer - Senior Vice President OPT+S $60.25 2,153 $129,724 12,131 0.0%
2011-05-11 22:26 2011-05-10 Hague Donald R. Officer - Senior Vice President OPT+S $61.93 2,078 $128,698 8,036 0.0%
2011-05-11 22:27 2011-05-10 LEENHOUTS NELSON B Director OPT+S $62.01 22,617 $1,402,514 4,002 0.0%
2011-04-01 18:12 2011-03-31 MCCORMICK ANN M Officer - EVP, Secretary & Gen. Counsel OPT+S $58.41 11,806 $689,630 77,470 0.0%
2011-03-15 22:39 2011-03-15 LEENHOUTS NELSON B Director SELL $54.74 100 $5,474 4,103 -2.4%
2011-03-09 23:32 2011-03-08 LEENHOUTS NORMAN P Director SELL $56.10 10,000 $561,032 0 -100.0%
2011-03-04 23:55 2011-03-04 Lydon Thomas P Jr Director BUY $56.27 1,800 $101,286 1,800 +100.0%
2011-03-04 00:58 2011-03-01 LEENHOUTS NELSON B Director SELL $57.54 691 $39,760 4,203 -14.1%
2011-02-25 23:04 2011-02-24 DOYLE SCOTT Officer - Senior Vice President OPT+S $56.00 6,765 $378,840 37,078 0.0%
2011-02-24 19:56 2011-02-23 SMITH JOHN E Officer - Senior Vice President OPT+S $56.41 20,317 $1,146,119 40,732 0.0%
2011-02-24 18:53 2011-02-23 HELBIG LEONARD F III Director SELL $56.31 3,000 $168,931 46,715 -6.0%
2010-12-29 20:32 2010-12-27 PETTINELLA EDWARD J Director, Officer - CEO OPT+S $55.55 74,400 $4,133,218 244,399 0.0%
2010-12-27 23:59 2010-12-22 PETTINELLA EDWARD J Officer - CEO OPT+S $55.64 25,600 $1,424,402 244,399 0.0%
2010-12-14 21:33 2010-12-10 Hague Donald R. Officer - Senior Vice President OPT+S $54.11 1,688 $91,343 8,091 0.0%
2010-12-08 23:54 2010-12-07 GARDNER DAVID P Officer - EVP, CFO OPT+S $55.25 11,806 $652,328 71,756 0.0%
2010-11-24 20:39 2010-11-23 LEENHOUTS NORMAN P Director SELL $53.01 10,000 $530,087 0 -100.0%
2010-09-07 20:51 2010-09-02 GARDNER DAVID P Officer - EVP, CFO SELL $52.26 3,000 $156,785 71,756 -4.0%
2010-08-25 21:44 2010-08-23 GARDNER DAVID P Officer - EVP, CFO SELL $49.08 10,000 $490,803 74,756 -11.8%
2010-08-19 20:08 2010-08-19 HELBIG LEONARD F III Director OPT+S $50.16 9,000 $451,467 49,715 0.0%
2010-08-19 20:07 2010-08-18 LEENHOUTS NORMAN P Director OPT+S $50.50 11,200 $565,600 941 0.0%
2010-08-10 22:41 2010-08-10 TAIT AMY L Director SELL $50.32 2,000 $100,640 3,036 -39.7%
2010-06-21 18:24 2010-06-18 LEENHOUTS NORMAN P Director SELL $49.57 479 $23,744 941 -33.7%
2010-06-18 18:39 2010-06-17 SMITH JOHN E Officer - Senior Vice President SELL $50.08 232 $11,617 34,805 -0.7%
2010-06-18 18:39 2010-06-17 DOYLE SCOTT Officer - Senior Vice President OPT+S $50.01 920 $46,005 37,078 0.0%
2010-06-17 21:27 2010-06-15 TAIT AMY L Director SELL $49.52 5,000 $247,607 5,000 -50.0%
2010-06-17 21:26 2010-06-15 MCCORMICK ANN M Officer - EVP, Secretary & Gen. Counsel OPT+S $49.53 9,171 $454,208 76,521 0.0%
2010-06-17 21:27 2010-06-17 LUKEN ROBERT Officer - Senior Vice President OPT+S $50.15 7,385 $370,358 33,606 0.0%
2010-06-14 17:48 2010-06-10 LUKEN ROBERT Officer - Senior Vice President SELL $48.41 1,377 $66,657 33,606 -3.9%
2010-05-25 17:16 2010-05-21 TAIT AMY L Director SELL $46.05 5,000 $230,270 10,000 -33.3%
2010-05-13 22:51 2010-05-12 LEENHOUTS NORMAN P Director OPT+S $51.51 10,000 $515,117 1,420 0.0%
2010-03-19 19:37 2010-03-18 LUKEN ROBERT Officer - Senior Vice President SELL $47.38 270 $12,793 32,333 -0.8%
2010-03-12 22:10 2010-03-10 TAIT AMY L Director OPT+S $46.76 2,675 $125,092 31,507 0.0%
2009-12-29 19:49 2009-12-28 GARDNER DAVID P Officer - EVP, CFO OPT+S $48.47 6,044 $292,962 77,687 0.0%
2009-12-07 23:14 2009-12-04 HELBIG LEONARD F III Director SELL $46.57 5,000 $232,832 51,715 -8.8%
2009-12-07 23:14 2009-12-04 GARDNER DAVID P Officer - EVP, CFO OPT+S $46.35 3,333 $154,486 75,153 0.0%
2009-11-24 22:31 2009-11-24 LEENHOUTS NORMAN P Director OPT+S $44.57 39,998 $1,782,595 1,774 0.0%
SHOW ENTRIES

How to Interpret $HME Trades

Not every insider transaction in HME is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HME shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HME

Insider activity data for HME is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HME, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.